Is Syncom Formulations (India) Ltd halal to invest in?

As of July 2026, Syncom Formulations (India) Ltd 524470.BO is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Syncom Formulations (India) Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Syncom Formulations (India) Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Syncom Formulations (India) Ltd?

Muslim investors may consider investing in Syncom Formulations (India) Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Syncom Formulations (India) Ltd classified as HALAL?

Musaffa determines the Shariah status of Syncom Formulations (India) Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Syncom Formulations (India) Ltd updated?

The Shariah compliance status of Syncom Formulations (India) Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Syncom Formulations (India) Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Syncom Formulations (India) Ltd?

You can check the latest Shariah compliance status of Syncom Formulations (India) Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Syncom Formulations (India) Ltd 524470.BO

Last Updated: Jul 17, 12:00 AM·BSE

524470.BO Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Syncom Formulations (India) Ltd is classified as halal.

HALAL

Report Source: 2026 3rd Quarter Report

Syncom Formulations (India) Ltd. Stock Analysis 524470.BO

India Health Care Micro Cap Report: Q3, 2026

Syncom Formulations (India) Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Indore, Maharashtra and currently employs 554 full-time employees. The firm is engaged in the development, manufacturing & sale of pharmaceutical products and services& trading of commodities and renting of properties. The firm manufactures and markets more than 200 pharmaceutical formulation products in various dosage forms, like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections and Dry Vial injections, Dry Syrups, Ointments and Inhalers. The firm's domestic division product categories include Cratus Life Care, Cratus Evolve and Cratus Right Nutrition. Its products include Ciprofloxacin Tablets USP 250 mg, Ciprofloxacin Tablets USP 500 mg, Ciprofloxacin Tablets USP 750 mg, Cefazolin For Injection USP 1 gm, Cefotaxime For Injection USP 1 gm, Ceftriaxone for Injection USP 500 mg, Albendazole Oral Suspension USP 100mg, Cetirizine Oral Solution BP, Clotrimazole Cream USP, Compound Benzoic Acid Ointment BP, and others.

Key Statistics of Syncom Formulations (India) Ltd (524470.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹13.30₹13.65

Today's Open

₹13.65

Volume

275.58K

P/E Ratio (TTM)

16.88

Financial Metrics & Statements of Syncom Formulations (India) Ltd (524470.BO)

Super Investors Invested in Syncom Formulations (India) Ltd (524470.BO)

FAQ's for Syncom Formulations (India) Ltd (524470.BO)

As of July 2026, Syncom Formulations (India) Ltd 524470.BO is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Syncom Formulations (India) Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Syncom Formulations (India) Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Syncom Formulations (India) Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Syncom Formulations (India) Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Syncom Formulations (India) Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.